ProShare Advisors LLC cut its position in Agilent Technologies, Inc. (NYSE:A) by 2.0% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 64,216 shares of the medical research company’s stock after selling 1,282 shares during the quarter. ProShare Advisors LLC’s holdings in Agilent Technologies were worth $3,809,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently made changes to their positions in A. Parallel Advisors LLC boosted its stake in shares of Agilent Technologies by 5.3% in the second quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock valued at $157,000 after purchasing an additional 131 shares during the period. Trust Co. of Vermont boosted its stake in shares of Agilent Technologies by 1.8% in the second quarter. Trust Co. of Vermont now owns 2,793 shares of the medical research company’s stock valued at $166,000 after purchasing an additional 50 shares during the period. Fiduciary Trust Co. purchased a new position in shares of Agilent Technologies in the second quarter valued at $186,000. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC boosted its stake in shares of Agilent Technologies by 17.2% in the second quarter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC now owns 3,319 shares of the medical research company’s stock valued at $196,000 after purchasing an additional 486 shares during the period. Finally, Teacher Retirement System of Texas purchased a new position in shares of Agilent Technologies in the second quarter valued at $200,000.

COPYRIGHT VIOLATION WARNING: This story was first posted by Daily Political and is the property of of Daily Political. If you are reading this story on another site, it was illegally copied and reposted in violation of United States and international trademark & copyright legislation. The original version of this story can be accessed at https://www.dailypolitical.com/2017/09/23/proshare-advisors-llc-has-3-81-million-stake-in-agilent-technologies-inc-a.html.

A has been the subject of several analyst reports. BidaskClub downgraded shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 13th. Deutsche Bank AG restated a “buy” rating and issued a $66.00 target price on shares of Agilent Technologies in a research note on Thursday, June 22nd. Morgan Stanley restated an “overweight” rating on shares of Agilent Technologies in a research note on Monday, July 10th. Wells Fargo & Company upgraded shares of Agilent Technologies from a “market perform” rating to an “outperform” rating and upped their target price for the company from $42.92 to $60.73 in a research note on Wednesday, July 12th. Finally, Barclays PLC restated a “buy” rating and issued a $67.00 target price on shares of Agilent Technologies in a research note on Wednesday, July 19th. Three equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Agilent Technologies has an average rating of “Buy” and an average target price of $63.91.

Shares of Agilent Technologies, Inc. (NYSE:A) opened at 65.78 on Friday. Agilent Technologies, Inc. has a 12-month low of $42.92 and a 12-month high of $66.45. The company has a 50-day moving average of $62.75 and a 200 day moving average of $58.31. The firm has a market capitalization of $21.17 billion, a PE ratio of 33.92 and a beta of 1.30.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Tuesday, August 15th. The medical research company reported $0.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.07. The business had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.09 billion. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. Agilent Technologies’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the company posted $0.49 earnings per share. On average, analysts predict that Agilent Technologies, Inc. will post $2.32 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 25th. Stockholders of record on Tuesday, October 3rd will be paid a $0.132 dividend. The ex-dividend date is Monday, October 2nd. This represents a $0.53 annualized dividend and a dividend yield of 0.80%. Agilent Technologies’s payout ratio is 27.32%.

In related news, Director Boon Hwee Koh sold 4,500 shares of the firm’s stock in a transaction on Wednesday, August 30th. The stock was sold at an average price of $63.63, for a total value of $286,335.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Didier Hirsch sold 1,200 shares of the firm’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $66.00, for a total value of $79,200.00. Following the completion of the transaction, the chief financial officer now directly owns 164,202 shares of the company’s stock, valued at $10,837,332. The disclosure for this sale can be found here. In the last 90 days, insiders sold 170,720 shares of company stock worth $10,795,039.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.